Management of prosthetic heart valve anticoagulation in pregnancy

ACC Current Journal Review

Volumn 12, Issue 4, 2003, Pages 17-22

  Dyke, David B S ^a,b   Igic, Petar G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; CLINICAL EXAMINATION; CULTURAL FACTOR; DISEASE ASSOCIATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG MEGADOSE; DRUG PACKAGING; FETUS DISEASE; FETUS WASTAGE; FLUOROSCOPY; HEALTH CARE PERSONNEL; HEART HEMODYNAMICS; HEART VALVE PROSTHESIS; HUMAN; INFORMATION PROCESSING; INTRACARDIAC THROMBOSIS; MATERNAL MORTALITY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICOLEGAL ASPECT; MORBIDITY; MORTALITY; OSTEOPENIA; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREGNANCY; REGISTER; RELIGION; REVIEW; TERATOGENICITY; THROMBOCYTOPENIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 0042863003     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-1458(03)00336-2     Document Type: Review

References (8)

1. Physicians Desk Reference. Murray L, Kelly GL, eds. 56th ed. Montvale, NJ: Medical Economics Co., Inc., 2002.
2. Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637–41.
3. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol 1998;32:1486–588.
4. Guidelines for prevention of thromboembolic events in valvular heart disease—Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995;16:1320–30.
5. Topol EJ, Casele H, Elkayam U, et al. Report and recommendations of the Anticoagulation in prosthetic valves and pregnancy consensus report (APPCR). Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Clinical Cardiology Consensus Reports. Oct 1, 2002.
6. Elkayam U. Pregnancy through a prosthetic heart valve. J Am Coll Cardiol 1999;33:1642–5.
7. Wiess BM, von Segesser LK, Alou E, et al. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 1998;179:1643–53.
8. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 1995;7:534–41.